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Introduction: Stereotactic body radiotherapy(SBRT) for early lung 
cancer results in excellent local control and potentially improved 
survival,but demands high levels of dose conformality. To achieve this 
with 3D-conformal radiotherapy(3D-CRT) and intensity modulated 
radiotherapy (IMRT) large numbers of beams, and non-coplanar 
techniques are often required. Hence treatment times are long, 
increasing the risk of patient motion. Volumetric arc therapy(VMAT) 
may result in improved dosimetric outcomes, and reduce treatment 
time. We report on a planning study comparing VMAT to coplanar (CP) 
and non-coplanar (NCP) 3D-CRT and IMRT, and our initial clinical 
results.  
Materials and Methods: Pinnacle VMAT, and CP and NCP 3D-CRT and 
IMRT plans for delivery on Elekta Linacs of 5 patients were 
compared.The following dosimetric characteristics were assessed: 
target coverage(coverage with the prescribed dose and 98% coverage 
of the PTV), dose conformality (100% conformity indices, D2cm and 
volume of tissue outside PTV receiving high dose, defined as >105% of 
prescription dose) and V20 (volume of lung receiving 20 Gy). A 
minimum of 10-12 beams were used for IMRT and 3D-CRT plans. VMAT 
plans were single arc with 4 degree spacing. Plans aimed to deliver 
the prescription dose to at least 98% of the volume, with a V20 ≤ 8% . 
All patients had peripheral tumours and received 48 Gy in 4 fractions.  
Results:  
Dosimetric Outcomes 
VMAT achieved equivalent radiotherapy target coverage to 3D-CRT 
and IMRT (>98.2%). However, 3D-CRT plans had a large volume of 
surrounding normal tissue receiving a high dose (24.0% and 21.3% of 
the PTV volume for CP and NCP respectively) when compared to VMAT 
and IMRT plans (3.9% and 4-5% of the PTV volume respectively). 100% 
conformity indices were lowest for VMAT and NCP IMRT (1.1 for both) 
and highest for 3D-CRT (1.5 and 1.4 for CP and NCP respectively). 
D2cm was also lowest for VMAT and NCP IMRT (26.1 Gy and 25.3 Gy) 
and highest for 3D-CRT plans (29.4 Gy and 28.7 Gy for CP and NCP 
respectively). V20 was between 4.4 and 6.1% for all plans. 
Clinical outcomes 
Clinical VMAT treatment time takes 35 minutes, and beam-on time is 8 
minutes. With short follow-up (range 4 weeks to 6 months), 1 patient 
has developed worsening dyspnoea, due to a chest infection. No other 
Grade 2 or greater toxicity was seen in the other 4 patients.  
Conclusions: Clinical implementation of VMAT was successfully 
demonstrated, and has resulted in fast treatment times for our SBRT 
lung patients. VMAT plans are similar in quality to NCP IMRT, but are 
much faster to deliver due to reduced gantry and couch movements. 
3D-CRT plans were unable to deliver equivalent dose conformality, 
and a much larger region of normal tissue was exposed to a high dose 
when equivalent PTV coverage was achieved.  
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Purpose/Objective: To assess the visibility of various fiducial markers 
for the application in stereotactic body radiation therapy of colorectal 
liver metastases. Breathing dynamics were mimicked with a 4D 
phantom and evaluated with helical tomotherapy MVCT. 
Materials and Methods: Initially, fifteen types of markers were 
imaged in a static water environment with MVCT. Poor visible markers 
on MVCT were eliminated leaving six markers for further evaluation in 
dynamic conditions.  
A 4D motion phantom was developed and validated to perform these 
measurements. A repetitive motion on the studied markers was 
applied in a water environment. Peak-to-peak amplitude and 
frequency was varied to analyze the effect of dynamic conditions on 
the marker detectability on MVCT of a helical tomotherapy system. A 
conventional 4D kVCT unit was used as reference. 
The detectability was quantified by analyzing the contrast of the 
fiducial markers on the obtained images. Also, the artifacts on the 
images caused by the moving markers were analyzed with respect to 
the amplitude and frequency of the movements.  
Results: Best contrast on MVCT was generated by the 'gold sphere' 
marker, but this marker generated unacceptable artifacts on kVCT. 
The ‘gold anchor’ marker provided the least artifacts on kVCT; 
however, visibility on MVCT was limited. All studied fiducial markers 
had good agreement between the average geometric position and the 
observed position on MVCT under the studied conditions. 
The size and number of the observed artifacts on MVCT were 
dependent on type of marker and specific dynamic conditions. 
Artifacts on MVCT improved the marker detectability and helped the 
observer to determine the center of the markers.  
Conclusions: Good detectability of all observed fiducial markers was 
obtained for the studied dynamical conditions. Good agreement was 
observed between the geometrical average position of the moving 
markers with respect to the observed position on MVCT. Artifacts 
generated by the MVCT-image processing can help in determining the 
position of the markers. 
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Purpose/Objective: Intensity Modulated Radiotherapy (IMRT) 
treatment planning for head and neck (H&N) cancer requires accurate 
delineation of target volumes, and these volumes could include 
several lymph node levels. Manual contouring of lymph nodes, in each 
CT slice, is a laborious and time consuming task; instead, it is more 
efficient to first perform automated segmentations and then followed 
by manual corrections if needed. It is shown in many recent works 
that the automated segmentations obtained by merging segmentation 
results obtained from multiple atlases are more accurate and robust 
than the results from a single atlas. In this work, we evaluate state-
of-the-art atlas fusion methods and our recently proposed fusion 
method for H&N lymph nodes segmentation. 
Materials and Methods: The fusion methods compared in this work 
are: (i) Majority Voting (MV), (ii) Global Weighted Voting (GWV), (iii) 
Local Weighted Voting (LWV), (iv) Shape Based Averaging (SBA), (v) 
Simultaneous Truth And Performance Level Estimation (STAPLE), and 
(vi) a Markov Random Field (MRF) based LWV method that we have 
proposed recently, which performs simultaneously both fusion and 
smoothing (LWV+MRF). In this evaluation, we consider 10 lymph node 
structures for automated segmentations: (i) IB-Left, (ii) IB-Right, (iii) 
IIA-Left, (iv) IIA-Right, (v) IIB-Left, (vi) IIB-Right, (vii) III-Left, (viii) III-
Right, (ix) IV-Left and (x) IV-Right. The dataset contains 12 atlas 
images and 8 patients' images to be segmented. For each image to be 
segmented, results obtained from 12 atlases are merged using all the 
above methods. 
Results: The quantitative evaluation is performed over the entire 
dataset, using two metrics; (i) Dice Similarity Measure (DSM): This is a 
commonly used metric that computes the measure of overlap (in %) 
between the ground truth and automated segmentations. (ii) Number 
of connected regions per label: The output segmentations of each 
lymph node should ideally contain a single contiguous region. Hence, 
we evaluate the fusion algorithms also based on the number of 
connected regions it creates per structure. Figure 1 presents box plots 
of average DSM computed across all lymph nodes. Among all fusion 
schemes, our LWV+MRF method provided the best results followed by 
LWV, GWV, MV, SBA and STAPLE respectively. Table 1 presents the 
average values of number connected regions per structure. Notice 
that LWV+MRF provided the best results, in terms of both these 
metrics. We also performed Wilcoxon signed rank test, and it is found 
(with p= 0.05) that the improvements in DSM from LWV+MRF when 
compared to the rest of the methods are statistically significant. 
 
 
Parameter  VMAT  3D-CRT 
CP  
3D-CRT 
NCP  
IMRT 
CP*  
IMRT- 
CP*  
PTV Coverage  98.2%  98.2%  98.3%  98.4%  98.4%  
V20  4.82%  5.1%  3.9%  5.4%  4.6%  
Mean Lung Dose  4.3 Gy 3.9 Gy  4.2 Gy  4.2 Gy  4.4 Gy  
High dose Spillage (% 
PTV volume)  
3.9%  24.02%  21.3%  5.2%  4.6%  
D2Cm 26.1 
Gy 
29.4 Gy 28.7 Gy 30.7 Gy 25.3 Gy 
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Conclusions: In this work, we evaluated 6 atlas fusion methods for 
automated segmentation of lymph nodes in the 3-D head and neck CT 
images. Among all the methods, our recently proposed Markov 
Random Field (MRF) based fusion method that performs 
simultaneously both local weighted voting based fusion and smoothing 
(LWV+MRF) provided the best results, both in terms of overlap 
measure and contiguous regions. 
Source of Funding: Swiss National Science Foundation under Grant 
205321-124797  
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Purpose/Objective: Delineation of esophageal tumours for 
radiotherapy treatment planning is currently done on CT images. 
Differentiating healthy tissue from tumour on CT is difficult due to 
poor soft tissue contrast. Thus, tumour delineation is predominantly 
based on identifying esophageal wall thickening. Determination of the 
tumour extent in the cranio-caudal (CC) direction remains particularly 
challenging. MRI with its various sequences can provide both 
anatomical and functional information. Diffusion-weighted MRI (DW-
MRI) makes it possible to identify areas with restricted diffusion, 
which occurs in many primary and metastatic tumors. This additional 
information may help to improve delineation of the treatment 
volume. The aim of this study is to assess the potential benefit of DW-
MRI in GTV delineation of esophageal tumours. 
Materials and Methods: Seven patients with esophageal cancer 
underwent a planning CT and an MRI scan. Scans were acquired within 
one week of each other. The MRI scan was performed on a 1.5T 
scanner and consisted of a diffusion-weighted MRI sequence (b = 800 
s/mm2) and T2w scans. Two physicians independently defined the GTV 
for each tumour: first on the CT images and then on the MR-images. 
The T2w images were used as anatomical images and were co-
registered to the DW-MRI scan. Consensus on the definition of CC 
tumour borders was evaluated by measuring the absolute difference 
between the delineations. Furthermore, inter-observer agreement 
was assessed using the conformity index (CI), defined as the ratio of 
common to encompassing volume. 
Results: The DW-MR images clearly showed areas of high contrast in 
the tumor region (fig. 1). Consequently the consensus on defining the 
caudal tumour border improved in 6 out of 7 patients when delineated 
on DW-MRI compared to CT. The median absolute difference between 
observers was 7mm on CT as opposed to 4mm on DW-MRI. Six out of 7 
caudal tumour borders were located near the gastro-esophageal 
junction (GEJ). Tumor delineation in this area is especially challenging 
with the CT-based delineations currently used in clinical practice. No 
difference was found in agreement on the cranial tumour border, with 
a median difference of 4mm between observers on both modalities. 
Delineations showed negligible disagreement in the transversal plane. 
This was also reflected in similar volumes delineated on CT and DW-
MRI (median: 59.7 vs. 58.3cm3). In this study with a small number of 
patients, the median CI showed no clear difference between 
modalities (CT: 0.77, range: 0.68-0.79 vs. DW-MRI: 0.75,range: 0.54-
0.84). However, an improvement in CI was seen in 5 out of 7patients 
on the DW-MRI based delineation. 
 
 
Conclusions: DW-MRI shows excellent contrast in esophageal tumours 
and consequently may be useful for esophageal tumour delineation. In 
comparison to CT-based delineations, our results demonstrate that 
DW-MRI is promising in defining tumour extent in the CC direction, 
especially in the caudal borders near the GEJ.  
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Purpose/Objective: In vivo dosimetry for intraoperative electron 
radiation therapy (IOERT) is challenging because of the non-reference 
conditions of the irradiated area. However, in vivo dosimetry is 
desirable for verification, recording and eventual correction of 
treatment. MOSFETs and radiochromic films have been used for these 
purposes, chiefly in breast treatments. The aim of our work is to share 
our first analysis on tumor bed absorbed dose evaluation regardless of 
its localization and begin a discussion on an action level (AL) for all 
treatments in general. 
Materials and Methods: Reinforced mobile MOSFETs model TN-
502RDM-H and Gafchromic MD-55-2 film were used. MOSFETs 
calibration involved a linear relationship between dose and voltage 
difference before and after irradiation. With regard to film 
calibration, polynomial fitting of the absorbed doses to the mean pixel 
values was performed. Associated uncertainties were also estimated. 
A general purpose LINAC was used for calibrations and treatments. 
Measurement uncertainties were assessed for both methods. 
Measurements were taken from 14 patients: 9 primary tumors (4 
rectal tumors, 2 breast, 1 abdominal sarcoma, 1 scapular sarcoma and 
1 lower limb skin tumor) and 5 relapses (3 presacral, 1 nodal and 1 
pancreatic recurrence) involving 15 pairs of measurements in total at 
the tumor bed. All data were normalized so that 100% corresponded to 
the maximum absorbed dose.  
Afterwards, two approaches to reviewing or compensating treatment 
involving AL were derived. They are formally equivalent, since AL = 
2u. In the first approach, u represents the uncertainty of a single 
measurement. However, in the second, u represents the mean 
standard error (MSE) of a series of measurements. AL should be added 
to the intended absorbed doses interval (e.g. 90%-100%). 
Results: The three identified sources of uncertainty of the measured 
absorbed dose were those associated with beam calibration, equal to 
0.4%, lack of linearity of linac output (e.g. 0.03 Gy in a typical 3000 
MU treatment) and detector response, totalling 1.7% in the case of 
MOSFETs and 2.4% in the case of films (1 SD). 
Descriptive statistics of our data are depicted in table 1. The two 
distributions (fig. 1) did not appear as significantly shifted when 
subjected to the Wilcoxon signed ranks test (p = 0.363). 
 
 
  
